About Steven Holtzman
Form D filings for Manifold Biotechnologies in 2024 list Steven Holtzman as director.
Steven Holtzman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Holtzman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Holtzman works with at each company, as listed on that company's latest Form D.
Manifold Biotechnologies, Inc. · Form D, Dec 3, 2024
JB
Jory Bell
Director
GK
Gleb Kuznetsov
Chief Executive Officer and director
JH
Jeff Huber
Director
PO
Pierce Ogden
Executive officer and director
SK
Steven Kafka
Director